Commercial opportunities for emerging infectious diseases vaccine developers
Although development of interventions for emerging infectious diseases (EIDs) has traditionally been limited by a lack of market incentives, novel funding mechanisms and global partnerships for outbreak preparedness are expanding the commercial prospects for vaccine developers, according to analytics company GlobalData
Breaking News
BioLingus partnership boosts WuXi STA’s solid dose potential
The collaboration will use BioLingus' technology to focus on sublingual and buccal drug delivery
Nemus and Pharmaceuticals International look to THC
Companies have agreed to develop a sterile eye drop dosage formulation, based on a cannabinoid, for Glaucoma
Catalent receives P&G External Business Partner of the Year Award
The award recognises the performance of the company's two state-of-the-art softgel manufacturing facilities in Ontario, ...
Platform solutions for biotech pharmaceuticals
Today’s innovative pharmaceuticals and new approaches to cell or gene therapies offer new treatment solutions for hard- ...
Collaboration brings inhalers online
Orion and Propeller have partnered to reduce the burden of chronic respiratory disease by connecting inhalers to mobile ...
Model-informed precision dosing gains scientific support
Certara has published four new papers to provide the necessary evidence to bring model-informed precision dosing to ...
Developments and the future of pharmaceutical packaging
With the global primary packaging market in the pharmaceutical sector expected to experience remarkable growth during ...
Pharmapack Europe 2019 reveals winners
Award winners have been selected for innovation in delivery, dosage and packaging of pharmaceutical products
Companies partner to improve vaginal rings
Particle Sciences and Encube Ethicals have announced partnership to develop new drug delivery vaginal rings aimed at ...
Capsule-based inhalers: part II
ACG's Justin Kalafat and Fernando Diez report on a useful tool in inhalation technology
Looking back on 2018 and making predictions for 2019
As the global pharmaceutical industry transitions from the knowns of 2018 into the unknowns of 2019, Dr Kevin Robinson ...
Capsule-based inhalers: part I
A useful tool in inhalation technology
Aptar Pharma to exhibit latest innovations in drug delivery devices at Pharmapack 2019
Aptar Pharma, a leading drug delivery systems provider, will once again be a major exhibitor at Pharmapack 2019, which ...
Second failure of AstraZeneca’s Imfinzi + tremelimumab combination significant setback says GlobalData
Following the news (Friday 7 December) that the combination did not improve overall survival versus standard-of-care ...
In Brief
Most Popular in Drug Delivery
Suppliers in drug delivery
Reports
